Comparison of standard prophylactic and preemptive therapeutic low molecular weight heparin treatments in hospitalized patients with COVID-19

---

Copur B., Surme S., Sayili U., Tuncer G., Zerdali E., Yazla M., ...Daha Fazla

BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, cilt.122, sa.9, ss.626-630, 2021 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 122 Sayı: 9
• Basım Tarihi: 2021
• Doi Numarası: 10.4149/bll_2021_100
• Dergi Adı: BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE, MEDLINE
• Sayfa Sayıları: ss.626-630
• Anahtar Kelimeler: anticoagulant therapy, COVID-19, Low-molecular-weight heparin (LMWH), mortality, outcome, CORONAVIRUS DISEASE 2019, ANTICOAGULATION
• İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet

Özet

INTRODUCTION: Anticoagulant treatment approach in patients with COVID-19 is not well studied and not standardized. We aimed to compare the effects of standard prophylactic and pre-emptive therapeutic Low-Molecular-weight Heparin (LMWH) treatment approaches on mortality in patients with COVID-19.